TR201808116T1 - İnsanlarda ve hayvanlarda kullanilmak üzere yeni̇ probi̇yoti̇k başlatici kültür - Google Patents
İnsanlarda ve hayvanlarda kullanilmak üzere yeni̇ probi̇yoti̇k başlatici kültür Download PDFInfo
- Publication number
- TR201808116T1 TR201808116T1 TR2018/08116T TR201808116T TR201808116T1 TR 201808116 T1 TR201808116 T1 TR 201808116T1 TR 2018/08116 T TR2018/08116 T TR 2018/08116T TR 201808116 T TR201808116 T TR 201808116T TR 201808116 T1 TR201808116 T1 TR 201808116T1
- Authority
- TR
- Turkey
- Prior art keywords
- culture
- animals
- lmg
- initiative
- people
- Prior art date
Links
- 241001465754 Metazoa Species 0.000 title abstract 2
- 239000006041 probiotic Substances 0.000 title abstract 2
- 230000000529 probiotic effect Effects 0.000 title abstract 2
- 235000018291 probiotics Nutrition 0.000 title abstract 2
- 241000186840 Lactobacillus fermentum Species 0.000 abstract 2
- 239000003999 initiator Substances 0.000 abstract 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 abstract 2
- 229940012969 lactobacillus fermentum Drugs 0.000 abstract 2
- 241000894006 Bacteria Species 0.000 abstract 1
- 206010022678 Intestinal infections Diseases 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 241000194020 Streptococcus thermophilus Species 0.000 abstract 1
- 230000000845 anti-microbial effect Effects 0.000 abstract 1
- 230000002519 immonomodulatory effect Effects 0.000 abstract 1
- 239000002955 immunomodulating agent Substances 0.000 abstract 1
- 230000002584 immunomodulator Effects 0.000 abstract 1
- 229940121354 immunomodulator Drugs 0.000 abstract 1
- 235000014655 lactic acid Nutrition 0.000 abstract 1
- 239000004310 lactic acid Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000002797 proteolythic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/46—Streptococcus ; Enterococcus; Lactococcus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Food Science & Technology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Buluşun konusu üç termofilik laktik asit bakterisinin (LAB) doğal izolatlarından oluşan yeni probiyotik başlatıcı kültürle ilgili olup bu izolatlar spesifik oranlarda bulunan Streptococcus thermophilus LMG P-28585 (BGVLJ1-44), Lactobacillus fermentum LMG P-28583 (BGHI14) ve Lactobacillus helveticus LMG P-24226 (BGRA43)?tür. Buluşa göre başlatıcı kültür proteolitik ve antimikrobiyal aktivite ve ayrıca immünomodülatör etki göstermektedir. Ayrıca buluş bu kültürün insanlarda ve hayvanlarda olmak üzere memelilerde bağırsak enfeksiyonlarının önlenmesinde ve/veya tedavisinde kullanılmasıyla ve immünomodülatör olarak kullanılmasıyla ilgilidir.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RS20150852A RS57471B1 (sr) | 2015-12-17 | 2015-12-17 | Nova probiotička starter kultura za humanu i animalnu primenu |
PCT/RS2015/000027 WO2017105267A1 (en) | 2015-12-17 | 2015-12-22 | New probiotic starter culture for human and animal use |
Publications (1)
Publication Number | Publication Date |
---|---|
TR201808116T1 true TR201808116T1 (tr) | 2018-07-23 |
Family
ID=55521778
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2018/08116T TR201808116T1 (tr) | 2015-12-17 | 2015-12-22 | İnsanlarda ve hayvanlarda kullanilmak üzere yeni̇ probi̇yoti̇k başlatici kültür |
Country Status (3)
Country | Link |
---|---|
RS (1) | RS57471B1 (tr) |
TR (1) | TR201808116T1 (tr) |
WO (1) | WO2017105267A1 (tr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112020011999A2 (pt) * | 2017-12-14 | 2020-11-17 | Pure Cultures 2020 Inc. | probióticos e metabólitos de fermentação para a prevenção e tratamento de doenças e afecções em animais |
BR112022012629A2 (pt) * | 2019-12-24 | 2022-09-06 | Univ Iowa State Res Found Inc | Controle de histamina para promover saúde e controlar enterocolite usando composições probióticas e/ou enzimas de degradação de histamina |
CN113197312A (zh) * | 2020-07-14 | 2021-08-03 | 内蒙古蒙牛乳业(集团)股份有限公司 | 嗜热链球菌mn002在免疫调节产品中的用途及膳食补充剂 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5656268A (en) | 1995-04-21 | 1997-08-12 | Sorodsky; Michael | Biological product |
EP0856259B1 (en) | 1996-12-23 | 1998-08-12 | SITIA-YOMO S.p.A. | Composition for feed use comprising lyophilized live lactic bacteria |
ES2284089T3 (es) | 2000-05-25 | 2007-11-01 | Societe Des Produits Nestle S.A. | Probioticos para aplicaciones en alimentos para animales domesticos. |
FI109602B (fi) | 2001-01-25 | 2002-09-13 | Valio Oy | Probioottiyhdistelmä |
EE04580B1 (et) * | 2001-06-29 | 2006-02-15 | Tartu �likool | Mikroorganismi tüvi Lactobacillus fermentum ME-3 kui antimikroobne ja antioksüdantne probiootikum |
EE05459B1 (et) | 2006-12-08 | 2011-08-15 | Tartu �likool | Sporogeense Bacillus smithii tvi TBMI12 MSCL P737 ja selle endospooride kasutamine probiootikumina, toidulisandina ning probiootiline kompositsioon |
ITMI20072260A1 (it) | 2007-12-03 | 2009-06-04 | Anidral Srl | Una composizione a base di batteri probiotici in associazione con un prebiotico e suo uso nella prevenzione e/o nel trattamento di patologie e/o infezioni respiratorie e nel miglioramento della funzionalita intestinale. |
RU2471359C1 (ru) | 2011-08-03 | 2013-01-10 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Орловский государственный аграрный университет" (ФГБОУ ВПО "Орел ГАУ") | Способ коррекции иммунобиологических показателей у поросят в период отъема |
RU2520840C2 (ru) | 2011-12-27 | 2014-06-27 | Государственное научное учреждение Всероссийский научно-исследовательский институт мясного скотоводства Российской академии сельскохозяйственных наук | Комплексный пробиотический препарат для крупного рогатого скота мясных пород |
CN102835609B (zh) | 2012-09-27 | 2013-11-27 | 山东新希望六和集团有限公司 | 具有防止仔猪腹泻作用的猪饲料和中药组合物 |
CN103039700B (zh) | 2013-01-09 | 2014-06-04 | 广州华农大实验兽药有限公司 | 一种用于兽药固体发酵饲料添加剂及其制备方法 |
CN103549141B (zh) | 2013-04-25 | 2016-05-11 | 北京生泰尔科技股份有限公司 | 一种猪用中草药复合益生菌饲料添加剂及其制备方法 |
-
2015
- 2015-12-17 RS RS20150852A patent/RS57471B1/sr unknown
- 2015-12-22 WO PCT/RS2015/000027 patent/WO2017105267A1/en active Application Filing
- 2015-12-22 TR TR2018/08116T patent/TR201808116T1/tr unknown
Also Published As
Publication number | Publication date |
---|---|
RS20150852A1 (sr) | 2017-06-30 |
RS57471B1 (sr) | 2018-09-28 |
WO2017105267A1 (en) | 2017-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP4257194A3 (en) | Use of microbial communities for human and animal health | |
WO2018229236A3 (en) | COMPOSITIONS COMPRISING BACTERIAL STRAINS | |
PH12015502416A1 (en) | Bacterial strains having antimicrobial activity and biocontrol compositions comprising the same | |
BR112018069284A2 (pt) | composição probiótica e seu uso no tratamento e/ou prevenção da psoríase | |
BR112019001116A2 (pt) | composição probiótica usada no tratamento e/ou prevenção da dermatite atópica | |
MX2017016748A (es) | Bacteria lactobacillus rhamnosus para el tratamiento de, por ejemplo, vaginosis bacteriana. | |
ZA201804863B (en) | Novel probiotic bacterial strain of lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation | |
TR201910280T4 (tr) | Mastitin tedavisine yönelik Lactobacillus salivarius. | |
RS54478B1 (en) | LACTOBACILLUS PLANTARUM MCC1 DSM 23881 ISOLATED MICRO-ORGANISM AND ITS USE | |
WO2018231992A3 (en) | METHODS OF USING LACTOBACILLUS PLANTARUM STRAINS TO PROTECT ANIMALS AGAINST PATHOGENIC BACTERIAL INFECTION | |
WO2019098810A3 (ko) | 신규 유산균 및 이의 용도 | |
EP3787668C0 (en) | PROBIOTIC BACTERIAL STRAINS THAT PRODUCE ANTIMICROBIAL PROTEINS AND COMPOSITIONS THEREOF FOR THE TREATMENT OF A CLOSTRIDIUM DIFFICILE INFECTION | |
BR112016026654A2 (pt) | Composições contendo ácido bórico e uma mistura de lactobacillus | |
TR201808116T1 (tr) | İnsanlarda ve hayvanlarda kullanilmak üzere yeni̇ probi̇yoti̇k başlatici kültür | |
WO2017199022A3 (en) | Lactobacillus rhamnosus lysate compositions and uses thereof | |
MX2017007969A (es) | Bacterias de acido lactico y su uso para el tratamiento de mastitis. | |
AU2019263623A8 (en) | Probiotic Bifidobacterium breve strain and compositions comprising said strain | |
MX2019006086A (es) | Uso de una composicion bacteriana para tratar infecciones en las patas de ungulados. | |
BR112019002023A2 (pt) | prevenção ou tratamento de infecções antifúngicas vetorizado por bactérias probióticas | |
TR201907851T4 (tr) | Örn. bakteriyel vajinozis tedavisine yönelik lactobacillus rhamnosus bakterisi. | |
AR101538A1 (es) | Cepas bacterianas que tienen actividad antimicrobiana y composiciones de biocontrol que las comprenden | |
MX2020001501A (es) | Streptococcus australis como bioterapeuticos. | |
RU2015107472A (ru) | Штамм бактерий Lactobacillus acidophilus Т-193, используемый при приготовлении ацидофильной закваски ("Ульцерин"), а также других лечебно-профилактических продуктов для лечения дисбактериоза и его последствий | |
UA93905U (uk) | Пробіотик "субалін" | |
MX2020007906A (es) | Composicion que comprende nuevas cepas de lactobacillus salivarius y metodo para la prevencion y el tratamiento de otitis e infecciones respiratorias de vias altas. |